المؤلفون: Christy Guyan, Mauricette Michallet, Rüdiger Hehlmann, Catherine Davis, Ronald Paquette, Carlo Gambacorti-Passerini, Clara Chen, Ginny P Sen, Stuart L. Goldberg

المساهمون: Gambacorti Passerini, C, Chen, C, Davis, C, Sen, G, Guyan, C, Hehlmann, R, Michallet, M, Paquette, R, Goldberg, S

المصدر: European Journal of Haematology

مصطلحات موضوعية: Male, Myeloid, observational studie, 0302 clinical medicine, MED/15 - MALATTIE DEL SANGUE, imatinib mesylate, dasatinib, Practice Patterns, Physicians', Aged, 80 and over, leukemia, Disease Management, Myeloid leukemia, Hematology, General Medicine, Middle Aged, Prognosis, Europe, Dasatinib, chronic, Leukemia, Treatment Outcome, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Leukemia, Myeloid, Chronic-Phase, Cohort, Female, Original Article, myeloid, Tyrosine kinase, medicine.drug, Adult, medicine.medical_specialty, Clinical Decision-Making, 03 medical and health sciences, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, observational studies, BCR‐ABL positive, chronic-phase, Aged, BCR-ABL positive, business.industry, chronic‐phase, Original Articles, medicine.disease, respiratory tract diseases, Imatinib mesylate, Observational study, business, Follow-Up Studies, 030215 immunology

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00833526e3e637d81cda9562ee4bb169
http://hdl.handle.net/10281/302184